We are live on ! Find out more
HIM

Hillsdale Investment Management Portfolio holdings

AUM $4.39B
1-Year Est. Return 72.96%
This Fund
S&P 500
This Quarter Est. Return
+6.11%
1 Year Est. Return
+72.96%
3 Year Est. Return
+270.97%
5 Year Est. Return
+506.63%
10 Year Est. Return
+3,190.25%
AUM
$1.98B
AUM Growth
+$679M
Cap. Flow
+$655M
Cap. Flow %
33.12%
Top 10 Hldgs %
31.04%
Holding
704
New
118
Increased
243
Reduced
134
Closed
128

Top Buys

Rank Stock Value
1
RY icon
Royal Bank of Canada
RY
+$85.2M
2
ENB icon
Enbridge
ENB
+$59.4M
3
MFC icon
Manulife Financial
MFC
+$53.9M
4
SHOP icon
Shopify
SHOP
+$50.3M
5
AEM icon
Agnico Eagle Mines
AEM
+$42.9M

Sector Composition

Rank Sector Weight
1 Financials 24.8%
2 Technology 17.19%
3 Materials 13.69%
4 Energy 13.39%
5 Industrials 10.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RMD icon
301
ResMed
RMD
$32.8B
$748K 0.04%
3,270
+100
+3% +$24.1K
MAS icon
302
Masco
MAS
$14.7B
$747K 0.04%
10,300
+10,100
+5,050% +$808K
MTD icon
303
Mettler-Toledo International
MTD
$28.8B
$746K 0.04%
+610
New +$796K
TSN icon
304
Tyson Foods
TSN
$19.6B
$744K 0.04%
12,950
+12,700
+5,080% +$767K
ACN icon
305
Accenture
ACN
$110B
$741K 0.04%
2,105
+1,050
+100% +$378K
HITI
306
High Tide
HITI
$205M
$738K 0.04%
240,288
+212,197
+755% +$601K
PM icon
307
Philip Morris
PM
$290B
$729K 0.04%
6,061
+2,890
+91% +$365K
HIG icon
308
Hartford Financial Services
HIG
$37.7B
$728K 0.04%
6,650
+350
+6% +$40.6K
LYFT icon
309
Lyft
LYFT
$6.28B
$726K 0.04%
56,300
-7,400
-12% -$110K
AXTA icon
310
Axalta
AXTA
$7.98B
$724K 0.04%
21,150
+800
+4% +$30.1K
INGR icon
311
Ingredion
INGR
$6.54B
$719K 0.04%
5,230
+5,100
+3,923% +$718K
APH icon
312
Amphenol
APH
$210B
$719K 0.04%
10,350
-500
-5% -$35K
EPAM icon
313
EPAM Systems
EPAM
$5.17B
$718K 0.04%
+3,070
New +$683K
MTCH icon
314
Match Group
MTCH
$8.4B
$708K 0.04%
21,650
+900
+4% +$30.8K
THC icon
315
Tenet Healthcare
THC
$21.5B
$707K 0.04%
5,600
+1,000
+22% +$149K
BIIB icon
316
Biogen
BIIB
$30.9B
$705K 0.04%
+4,610
New +$778K
FTV icon
317
Fortive
FTV
$18.6B
$704K 0.04%
12,447
+531
+4% +$30.5K
DXC icon
318
DXC Technology
DXC
$1.71B
$699K 0.04%
35,000
-900
-3% -$19K
BLD
319
DELISTED
TopBuild
BLD
$699K 0.04%
+2,245
New +$823K
LLY icon
320
Eli Lilly
LLY
$1.09T
$696K 0.04%
902
-260
-22% -$215K
ADT icon
321
ADT
ADT
$5.34B
$694K 0.04%
100,500
+4,400
+5% +$32K
BDX icon
322
Becton Dickinson
BDX
$50B
$694K 0.04%
3,060
+50
+2% +$11.5K
CCK icon
323
Crown Holdings
CCK
$13.1B
$693K 0.04%
+8,380
New +$763K
LDOS icon
324
Leidos
LDOS
$17.6B
$693K 0.04%
4,810
-1,000
-17% -$166K
NOV icon
325
NOV
NOV
$7.45B
$685K 0.03%
+46,900
New +$733K

Similar funds

Hillsdale Investment Management's Q4 2024 Portfolio in Review

As of Q4 2024, Hillsdale Investment Management held 704 positions worth $1.98B, up 52% from $1.3B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Hillsdale Investment Management deployed $655M of net new capital in Q4 2024, opening 118 new positions and adding to 243 existing holdings. Its largest new stake was Methanex: 767,330 shares worth $38.3M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, up from 13% a quarter earlier, followed by Technology and Materials.

On the sell side, the largest reduction was Celestica, an estimated $37M trimmed.

  • Hillsdale Investment Management's largest Q4 2024 buy was Methanex: 767,330 shares worth $38.3M.
  • Hillsdale Investment Management added most to Royal Bank of Canada in Q4 2024, an estimated $85.2M increase.
  • Hillsdale Investment Management's biggest Q4 2024 reduction was Celestica, cutting an estimated $37M.
  • Hillsdale Investment Management fully exited Primo Water Corporation in Q4 2024, selling an estimated $24.9M.
  • Hillsdale Investment Management's ten largest holdings make up 31% of its $1.98B portfolio in Q4 2024.
  • Hillsdale Investment Management opened 118 new positions and closed 128 in Q4 2024.
  • Hillsdale Investment Management's portfolio value rose 52% quarter-over-quarter to $1.98B.

Based on Hillsdale Investment Management's 13F filing for Q4 2024, filed 11 Feb 2025.